Searched for
TORRENT PHARMA SHARES
Capitalmind Flexi Cap Fund exits Vedanta and 10 others; adds 9 stocksDeepak Shenoy-backed Capitalmind Flexi Cap Fund exited 11 stocks, including Vedanta and Vedanta Oil and Gas, and added nine stocks, includi...- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian equities extended losses as fading Middle East peace hopes, elevated crude prices, rising US yields and weak global cues intensified...
- Mutual funds raise IT exposure to 6.6% in July after record low. Is sentiment towards tech improving?In July, mutual funds increased their allocation to the IT sector to 6.6 per cent, marking a positive shift after an extended period of min...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Ahead of Market: 10 things that will decide stock market action on MondayThe Indian stock market rallied around 3% over the last week, recouping its early losses despite global volatility. Analysts expect the mar...
- Torrent Pharmaceuticals Q1 Results: Profit rises 3% to Rs 566 croreTorrent Pharmaceuticals announced a robust profit after tax of Rs 566 crore for the first quarter, showcasing impressive growth. Revenue so...
- Sun Pharma, Cipla & other pharma stocks shed over 2% as Trump announces up to 200% tariffs on generic drugs from 2028Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff...
- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian markets ended lower as escalating Iran-US tensions and rising crude prices weighed on sentiment. Analysts expect geopolitical risks,...
- Ahead of Market: 10 things that will decide stock market action on FridayIndian equities ended subdued as geopolitical tensions capped gains despite optimism around Q1 earnings. Analysts expect stock-specific act...
- Quant Mid Cap Fund exits Reliance Industries and 3 others, adds BHEL, 1 other stock in JuneQuant Mid Cap Fund exited Reliance Industries and three other stocks in June while adding BHEL and L&T Technology Services to its portfolio...
- Ahead of Market: 10 things that will decide stock market action on ThursdayIndian equities ended marginally higher after surrendering most intraday gains. Softer US inflation data supported sentiment, while elevate...
- Capitalmind Flexi Cap Fund drops Vedanta Power, Vedanta Iron & Steel and 8 other stocks in June. Check detailsCapitalmind Flexi Cap Fund completely exited 10 stocks, including Vedanta Power and Vedanta Iron and Steel, in June while adding seven new ...
- Ahead of Market: 10 things that will decide stock market action on ThursdayIndian equities posted their steepest single-day decline since March as rising crude prices, renewed Middle East tensions and weak global c...
- Torrent Pharma shares in focus after CCI clears Rs 19,500 crore acquisition of JB ChemicalsTorrent Pharmaceuticals shares are expected to see activity. The Competition Commission of India has approved Torrent Pharma's plan to acqu...
- Torrent Pharma shares surge 4% after agreeing to acquire JB Chemicals for Rs 11,900 croreTorrent Pharmaceuticals will acquire a controlling stake in J.B. Chemicals. The deal is worth Rs 11,917 crore. Torrent Pharma approved the ...
- Torrent Pharma shares fall 3% after 2.9% stake sale via block dealTorrent Pharma Share Price: Torrent Pharmaceuticals reported a consolidated profit after tax (PAT) of Rs 453 crore in the September quarter...
- Torrent Pharma posts 24% jump in net profit to Rs 386 crore in Q2FY24India sales that constitute over half of Torrent's revenues grew 18% YoY to Rs 1,444 crores in Q2FY24. Torrent said the growth was led by c...
- Torrent Pharma shares jump 8% on strong Q4 earnings. How to trade stock now?Torrent Pharmaceuticals' shares surged 8% after the company reported a profit of INR 287 crore ($38.4m) during Q4 FY22, compared to a net l...
- Torrent Pharma post Rs 118 crore net loss in Q4FY22The earnings before interest, tax, depreciation and amortisation (EBITDA) margins dropped 300 basis points YoY to 29% in Q1FY22.
- Torrent Pharma Q2 results: Consolidated net profit up 2% at Rs 316 croreNet sales increased to Rs 2,103 crore during the quarter under review from Rs 1,985 crore in the year-ago period, Torrent Pharma said in a ...
Load More
